Camille B.
- Country
- France
- Department
- Thyroid disease and Endocrine Tumor Department
Research Overview
- Open-Label Rollover Study of AMG 732 in Thyroid Eye Disease Nonresponders and Relapsed Participants
- Phase 3 Randomized Double‑Masked Placebo‑Controlled Study of Subcutaneous Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
- Evaluation of Safety and Tolerability of VRDN-003 in Patients with Thyroid Eye Disease: A Randomized, Double-Masked, Controlled Study
Data & Insights
Has run more than one trial at 20 of 109 partner sites.
Specializations
Oncology and Haematologic Malignancies
Clinical research activity includes advanced solid tumours, non-small cell lung cancer, hepatocellular carcinoma, gastrointestinal cancers, breast cancer, ovarian cancer, urothelial carcinoma, and a broad range of lymphomas, leukaemias, and multiple myeloma.
- Solid tumours
- Hematologic cancers
- Gastrointestinal oncology
- Thoracic oncology
- Genitourinary oncology
Interest extends to targeted therapy, immunotherapy, and cellular therapy across relapsed, refractory, and advanced malignant disease.
Autoimmune, Inflammatory, and Rare Immune-Mediated Diseases
The investigator is involved in trials spanning systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, psoriatic arthritis, Sjögren’s disease, systemic sclerosis, vasculitis, sarcoidosis, and idiopathic inflammatory myopathies.
- Systemic autoimmune disease
- Vasculitis
- Connective tissue disease
- Inflammatory myopathy
- Granulomatous disease
Additional work covers immune thrombocytopenia, myasthenia gravis, uveitis, and other immune-mediated disorders with unmet therapeutic need.
Neurology and Neurodegenerative Disorders
Research interests include multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, progressive supranuclear palsy, and frontotemporal dementia.
- Demyelinating disease
- Movement disorders
- Neurodegeneration
- Motor neuron disease
- Cognitive decline
The portfolio also includes epilepsy, neuropathies, myasthenic syndromes, and rare neurologic diseases linked to progressive disability.
Cardiovascular, Renal, and Metabolic Disease
Clinical studies address heart failure, acute coronary syndromes, myocardial infarction, atrial fibrillation, stroke, pulmonary hypertension, chronic kidney disease, and kidney transplant rejection.
- Heart failure
- Atherosclerotic cardiovascular disease
- Renal disease
- Thromboembolic disease
- Metabolic dysfunction-associated steatotic liver disease
Work also spans diabetes, obesity, dyslipidaemia, liver cirrhosis, and amyloid cardiomyopathy, reflecting a strong focus on chronic cardiometabolic and organ-failure conditions.
Infectious Disease, Critical Care, and Transplant Medicine
Trial activity includes HIV infection, hepatitis B, hepatitis C, COVID-19, sepsis, acute respiratory distress syndrome, pneumonia, mycobacterial infection, and mpox.
- Critical care
- Viral infection
- Fungal infection
- Transplant complications
- Intensive care medicine
Additional involvement covers hematopoietic stem cell transplantation, graft-versus-host disease, opportunistic infections, and antimicrobial-resistant infection.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.